Innophos Recognized for Commitment to Board Diversity
19 Septembre 2019 - 3:00PM
Business Wire
Announces Participation in Women Business
Leadership Events
Innophos Holdings, Inc. announced today that it has been
recognized by the Executive Women of New Jersey (EWNJ) organization
and the 2020 Women on Boards campaign for its commitment to board
diversity. In addition, in support of the company’s commitment to
empowering women in business, Dr. Kim Ann Mink, Chairman, President
& CEO, will participate as a featured speaker at two upcoming
women business leadership events.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190919005193/en/
Dr. Kim Ann Mink, Chairman, President
& CEO of Innophos (Photo: Business Wire)
Innophos, which achieved gender parity on its Board of Directors
in 2018, was recently named to EWNJ’s biennial “A Seat at the Table
Honor Roll” list recognizing the impact the company has made on
gender diversity by appointing three or more women to its corporate
Board of Directors. The company also was recently awarded the 2020
Women on Boards Winning “W” Company Certificate in recognition of
having more than 20% female board representation.
“Diversity and inclusion are an integral part of our culture and
our strategy, and we are honored to be recognized for that,” said
Dr. Mink. “Our ongoing commitment to create a culture of inclusion
throughout the organization – from our Board of Directors to our
executive team and across our entire employee base – is key to our
success and benefits the Innophos team, our customers and our
shareholders.”
With 50% women representation on its board, Innophos is in good
but limited company with only 10 S&P 500 companies having
boards that are comprised of at least 50% women, according to The
Washington Post. 43% of Innophos’ executive team are female.
Advocating for the Advancement of Women in the Workplace
The company has a long-standing commitment to supporting the
advancement of women in the workplace. CEO Kim Ann Mink will
participate in two upcoming events to continue this tradition.
On Friday, September 20th, Dr. Mink will participate as a
panelist at the New Jersey Business & Industry Association’s
(NJBIA) 5th Annual Women Business Leaders Forum where more than 500
women and men from across the state of New Jersey will gather to
exchange ideas, gain leadership skills and identify ways to help
women make headway in corporate leadership.
On Tuesday, September 24th, Dr. Mink will join EWNJ for a Master
Class event, where she will participate in a conversation with the
organization’s President Emerita Michellene Davis, Esq., EVP &
Chief Corporate Affairs Officer at RWJBarnabas Health, on a variety
of leadership topics including the role of mentorship and
sponsorship in career success, leadership attributes critical to
successfully navigating career challenges, and Dr. Mink’s personal
career journey from scientist to CEO.
“I am honored to participate in these two upstanding leadership
events that reflect my personal commitment to advance the role of
women in business, as well as Innophos’ longstanding support of
diversity and inclusion as core organizational values,” said Dr.
Mink.
For more information about how Innophos is a leader in
advocating for equal access and opportunity, please visit
www.innophos.com.
About the Company Innophos
is a leading international producer of essential ingredients. We
partner with world-leading health & nutrition, food &
beverage and industrial brands to create science-based solutions
that improve quality of life. Our knowledgeable teams apply science
to unlock the potential that lies within the blends and
formulations that we deliver. Forward thinking and people centric
at heart, we execute with purpose and efficiency to create value in
everything we do. Headquartered in Cranbury, New Jersey, Innophos
has manufacturing operations across the United States, in Canada,
Mexico and China. For more information, please visit
www.innophos.com 'IPHS-G'
SOURCE Innophos Holdings, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190919005193/en/
Investor Contact Mark Feuerbach Innophos 609-366-1204
investor.relations@innophos.com Media Contact Ryan Flaim
Sharon Merrill Associates 617-542-5300
iphs@investorrelations.com
Innophos (NASDAQ:IPHS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Innophos (NASDAQ:IPHS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024